Surgeon-Led Initiatives to Increase Access to Surgical Treatment of Epilepsy at an Academic Level 4 Epilepsy Center: An Observational Cohort Study.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 07 2022
Historique:
received: 13 10 2021
accepted: 30 01 2022
pubmed: 7 4 2022
medline: 10 6 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

Underutilization of surgical treatment for epilepsy is multifactorial, and the multidisciplinary nature of caring for these patients represents a significant hurdle in expanding surgical treatment of epilepsy. To develop internal and external surgical referral relationships for patients with medically refractory epilepsy with the goal of improving access to care. To expand access to surgical epilepsy treatment at University of California (UC)-Irvine, 4 broad approaches focused on developing referral relationships and process improvement of surgical evaluation were undertaken in 2015 and 2016. The authors performed a retrospective review of all surgical epilepsy case referrals of the senior author from 2014 through 2020. Epilepsy surgical volume at UC-Irvine increased from an average of 5.2 cases annually to 32 cases in the first year (2015) of implementation. There was continued case volume growth from 2015 through 2020 to 52 procedures in the most recent year (P = .03). Hospital payments for epilepsy procedures increased from $1.09M in 2015 to $2.02M and $1.8M in 2019 and 2020 (P < .01), respectively, while maintaining a diverse payer mix. 79.4% of these patients did not have a previously established option for surgical epilepsy care. We outline strategies that level 4 epilepsy centers may use to strengthen collaborations and improve patient access for surgical epilepsy treatment. Increased collaboration can both improve the number of patients with epilepsy with access to specialized surgical care and produce reimbursement benefits for the centers caring for these patients, regardless of insurance source.

Sections du résumé

BACKGROUND
Underutilization of surgical treatment for epilepsy is multifactorial, and the multidisciplinary nature of caring for these patients represents a significant hurdle in expanding surgical treatment of epilepsy.
OBJECTIVE
To develop internal and external surgical referral relationships for patients with medically refractory epilepsy with the goal of improving access to care.
METHODS
To expand access to surgical epilepsy treatment at University of California (UC)-Irvine, 4 broad approaches focused on developing referral relationships and process improvement of surgical evaluation were undertaken in 2015 and 2016. The authors performed a retrospective review of all surgical epilepsy case referrals of the senior author from 2014 through 2020.
RESULTS
Epilepsy surgical volume at UC-Irvine increased from an average of 5.2 cases annually to 32 cases in the first year (2015) of implementation. There was continued case volume growth from 2015 through 2020 to 52 procedures in the most recent year (P = .03). Hospital payments for epilepsy procedures increased from $1.09M in 2015 to $2.02M and $1.8M in 2019 and 2020 (P < .01), respectively, while maintaining a diverse payer mix. 79.4% of these patients did not have a previously established option for surgical epilepsy care.
CONCLUSION
We outline strategies that level 4 epilepsy centers may use to strengthen collaborations and improve patient access for surgical epilepsy treatment. Increased collaboration can both improve the number of patients with epilepsy with access to specialized surgical care and produce reimbursement benefits for the centers caring for these patients, regardless of insurance source.

Identifiants

pubmed: 35384922
doi: 10.1227/neu.0000000000001961
pii: 00006123-202207000-00019
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-172

Informations de copyright

Copyright © Congress of Neurological Surgeons 2022. All rights reserved.

Références

Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness, Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311-318.
Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922-930.
Bjellvi J, Olsson I, Malmgren K, Wilbe Ramsay K. Epilepsy duration and seizure outcome in epilepsy surgery: a systematic review and meta-analysis. Neurology. 2019;93(2):e159–e166.
Cramer SW, McGovern RA, Wang SG, Chen CC, Park MC. Resective epilepsy surgery: assessment of randomized controlled trials. Neurosurg Rev. 2021;44(4):2059–2067.
Samanta D, Ostendorf AP, Willis E, et al. Underutilization of epilepsy surgery: Part I: a scoping review of barriers. Epilepsy Behav. 2021;117:107837.
Kobau R, Sapkota S, Koh HK, Zack MM. National declines in the percentages of uninsured among adults aged 18-64 years with active epilepsy, 2010 and 2013 to 2015 and 2017-U.S. National Health Interview Survey. Epilepsy Behav. 2019;97:316-318.
Samanta D, Singh R, Gedela S, Scott Perry M, Arya R. Underutilization of epilepsy surgery: part II: strategies to overcome barriers. Epilepsy Behav. 2021;117:107853.
Vadera S, Chan AY, Mnatsankanyan L, et al. Strategic hospital partnerships: improved access to care and increased epilepsy surgical volume. Neurosurg Focus. 2018;44(5):E9.
Drees C, Sillau S, Brown MG, Abosch A. Preoperative evaluation for epilepsy surgery: process improvement. Neurol Clin Pract. 2017;7(3):205-213.
Zhang K, Zhang J, Ma Y, Shao X, Hu W, Zhao B. The cultivation of epilepsy neurosurgeons: requirements and challenges. Chin Neurosurg J. 2016;2(1):18.
Englot DJ, Ouyang D, Garcia PA, Barbaro NM, Chang EF. Epilepsy surgery trends in the United States, 1990-2008. Neurology. 2012;78(16):1200-1206.
Kaiboriboon K, Malkhachroum AM, Zrik A, et al. Epilepsy surgery in the United States: analysis of data from the National Association of Epilepsy Centers. Epilepsy Res. 2015;116:105-109.
Jehi L, Friedman D, Carlson C, et al. The evolution of epilepsy surgery between 1991 and 2011 in nine major epilepsy centers across the United States, Germany, and Australia. Epilepsia. 2015;56(10):1526-1533.
Cloppenborg T, May TW, Blümcke I, et al. Trends in epilepsy surgery: stable surgical numbers despite increasing presurgical volumes. J Neurol Neurosurg Psychiatry. 2016;87(12):1322-1329.
Bien CG, Raabe AL, Schramm J, Becker A, Urbach H, Elger CE. Trends in presurgical evaluation and surgical treatment of epilepsy at one centre from 1988-2009. J Neurol Neurosurg Psychiatry. 2013;84(1):54-61.
Neligan A, Haliasos N, Pettorini B, Harkness WF, Solomon JK. A survey of adult and pediatric epilepsy surgery in the United Kingdom. Epilepsia. 2013;54(5):e62-5.
World Health Organization. ILAE/IBE/WHO Global Campaign Against Epilepsy. Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe; 2016.
Baud MO, Perneger T, Rácz A, et al. European trends in epilepsy surgery. Neurology. 2018;91(2):e96-e106.

Auteurs

Tyler S Cole (TS)

Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.

Sumeet Vadera (S)

Department of Neurosurgery, UC Irvine Medical Center, Orange, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH